Genecis Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 49

Genecis General Information

Description

Operator of a climate biotech company intended to convert waste into polymers, including polyhydroxyalkanoate bioplastics. The company's products include bio-based and biodegradable plastic, single-use foodware and packaging, three-dimensional-printing filaments, and the moldable plastic needed for the printing process, enabling customers to dispose of waste in a biodegradable manner.

Contact Information

Website
www.genecis.co
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 700 Bay Street
  • Suite 1100
  • Toronto, Ontario M5G 1Z6
  • Canada
+1 (844)
Primary Industry
Plastic Containers and Packaging
Other Industries
Environmental Services (B2B)
Corporate Office
  • 700 Bay Street
  • Suite 1100
  • Toronto, Ontario M5G 1Z6
  • Canada
+1 (844)

Genecis Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genecis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
24. Later Stage VC 02-Apr-2026 Completed Generating Revenue
23. Secondary Transaction - Private Completed Generating Revenue
22. Mezzanine 18-Jun-2025 Completed Generating Revenue
21. Later Stage VC 01-Jan-2025 Completed Generating Revenue
20. Accelerator/Incubator 01-Oct-2024 Completed Generating Revenue
19. Accelerator/Incubator Completed Generating Revenue
18. Accelerator/Incubator 01-Apr-2023 Completed Generating Revenue
17. Later Stage VC (Series A2) 10-Mar-2023 Completed Generating Revenue
16. Later Stage VC (Series A) 20-Jul-2022 $10M $15M Completed Generating Revenue
15. Early Stage VC 27-Oct-2021 $5.02M Completed Generating Revenue
To view Genecis’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Genecis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a climate biotech company intended to convert waste into polymers, including polyhydroxyalkanoate bioplastic
Plastic Containers and Packaging
Toronto, Canada
12 As of 2026

Emporia, KS
 

Portland, OR
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genecis Competitors (4)

One of Genecis’s 4 competitors is Green Dot Bioplastics, a Venture Capital-Backed company based in Emporia, KS.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Green Dot Bioplastics Venture Capital-Backed Emporia, KS
BioSphere Plastic Corporation Portland, OR
Forschungsinstitut Kunststoff und Recycling Corporation Willich, Germany
BiologiQ Formerly VC-backed Idaho Falls, ID
To view Genecis’s complete competitors history, request access »

Genecis Patents

Genecis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260070733-A1 Apparatus and methods for brewing tea via pods Pending 06-Sep-2024
US-12031122-B2 Recombinant bacterial cells and methods for producing poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Active 17-May-2022
US-12031123-B2 Recombinant bacterial cells and methods for producing poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Active 17-May-2022
US-20230374445-A1 Recombinant bacterial cells and methods for producing poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Active 17-May-2022
US-20230374557-A1 Recombinant bacterial cells and methods for producing poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Active 17-May-2022 C12P7/625
To view Genecis’s complete patent history, request access »

Genecis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genecis Investors (49)

Investor Name Investor Type Holding Investor Since Participating Rounds
Z-Park Fund Venture Capital Minority
Antares Ventures Venture Capital Minority
Bridge Ventures (Chicago) Family Office Minority
Canopus Advisors Growth/Expansion Minority
Ferocity Capital Venture Capital Minority
You’re viewing 5 of 49 investors. Get the full list »

Genecis FAQs

  • When was Genecis founded?

    Genecis was founded in 2017.

  • Where is Genecis headquartered?

    Genecis is headquartered in Toronto, Canada.

  • What is the size of Genecis?

    Genecis has 12 total employees.

  • What industry is Genecis in?

    Genecis’s primary industry is Plastic Containers and Packaging.

  • Is Genecis a private or public company?

    Genecis is a Private company.

  • What is Genecis’s current revenue?

    The current revenue for Genecis is .

  • How much funding has Genecis raised over time?

    Genecis has raised $20M.

  • Who are Genecis’s investors?

    Z-Park Fund, Antares Ventures, Bridge Ventures (Chicago), Canopus Advisors, and Ferocity Capital are 5 of 49 investors who have invested in Genecis.

  • Who are Genecis’s competitors?

    Green Dot Bioplastics, BioSphere Plastic, Forschungsinstitut Kunststoff und Recycling, and BiologiQ are competitors of Genecis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process